Neurology Clinical Trials

Statistical methods in neurology trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

All neurology trials

1,213 results

• Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation: Complete Statistical AnalysisIndependent statistical analysis of Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01288235).Phase 2Results postedn = 100NCT01288235
• Providing Brain Control of Extracorporeal Devices to Patients With Quadriplegia: Complete Statistical AnalysisIndependent statistical analysis of Providing Brain Control of Extracorporeal Devices to Patients With Quadriplegia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01849822).Phase NAResults postedn = 1NCT01849822
• PTP-NPIndependent statistical analysis of Improving Functions in Veterans With Post-traumatic Peripheral Neuropathic Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02979925).Phase NAResults postedn = 57NCT02979925
• PULSIndependent statistical analysis of Efficacy of Pantoprazole in Patients Older Than 12 Years With Reflux Associated Sleep Disorders (PULS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase NAResults postedn = 8,616NCT00562094
• PUMPIndependent statistical analysis of Prometra's Utilization in Mitigating Pain (PUMP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00817596).Phase NAResults postedn = 110NCT00817596
• PUMP-ExIndependent statistical analysis of Exercise-primed Upper Extremity Motor Practice in Chronic Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04259424).Phase NAResults postedn = 10NCT04259424
• Pupillary Unrest as an Indicator of Central Opioid Effect in Subjects 40-60 Years of Age: Complete Statistical AnalysisIndependent statistical analysis of Pupillary Unrest as an Indicator of Central Opioid Effect in Subjects 40-60 Years of Age: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2/3Results postedn = 10NCT05391555
• PuraBond PROOFIndependent statistical analysis of PuraBond® and Pain Following Resection of Oral or Oropharyngeal Mucosal Lesions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 73NCT05773781
• Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 3NCT00794313
• R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas: Complete Statistical AnalysisIndependent statistical analysis of R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 62NCT00021541
• RAAS and Arterial Stiffness in SCI: Complete Statistical AnalysisIndependent statistical analysis of RAAS and Arterial Stiffness in SCI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04510974).Phase NAResults postedn = 33NCT04510974
• Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 3Results postedn = 1,173NCT00304031
• Radiofrequency Hyperthermia Safety Study: Complete Statistical AnalysisIndependent statistical analysis of Radiofrequency Hyperthermia Safety Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05399771).Phase NAResults postedn = 20NCT05399771
• RALLYIndependent statistical analysis of A Phase 3 Study To Evaluate The Efficacy And Safety Of TNX-102 SL In Patients With Fibromyalgia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 3Results postedn = 514NCT04508621
• Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy: Complete Statistical AnalysisIndependent statistical analysis of Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 3Results postedn = 30NCT00195013
• RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS: Complete Statistical AnalysisIndependent statistical analysis of RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00126672).Phase 2Results postedn = 36NCT00126672
• Rapid MRI for Acute Pediatric Head Trauma: Complete Statistical AnalysisIndependent statistical analysis of Rapid MRI for Acute Pediatric Head Trauma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03291964).Phase NAResults postedn = 76NCT03291964
• RAS-HIVIndependent statistical analysis of Angiotensin Receptors and Age Related Mitochondrial Decline in HIV Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02606279).Phase NAResults postedn = 1NCT02606279
• RCT (Randomized Controlled Trial) of IV Acetaminophen for Post Operative Vaginal Reconstruction Pain: Complete Statistical AnalysisIndependent statistical analysis of RCT (Randomized Controlled Trial) of IV Acetaminophen for Post Operative Vaginal Reconstruction Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 4Results postedn = 100NCT02043704
• Real-PD Trial: Development of Clinical Prognostic Models for Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Real-PD Trial: Development of Clinical Prognostic Models for Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02474329).Phase NAResults postedn = 304NCT02474329
• Reanimation in Tetraplegia: Complete Statistical AnalysisIndependent statistical analysis of Reanimation in Tetraplegia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01997125).Phase NAResults postedn = 1NCT01997125
• Rebif® Pregnancy Registry: Complete Statistical AnalysisIndependent statistical analysis of Rebif® Pregnancy Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00338741).Phase NAResults postedn = 36NCT00338741
• RECOVERIndependent statistical analysis of Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00474058).Phase 3Results postedn = 287NCT00474058
• Reducing Asymmetry During Gait Using the TPAD (Tethered Pelvic Assist Device) for Stroke Patients: Complete Statistical AnalysisIndependent statistical analysis of Reducing Asymmetry During Gait Using the TPAD (Tethered Pelvic Assist Device) for Stroke Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase NAResults postedn = 12NCT03203291
• Reducing Falls With RENEW in Older Adults Who Have Fallen: Complete Statistical AnalysisIndependent statistical analysis of Reducing Falls With RENEW in Older Adults Who Have Fallen: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01080196).Phase NAResults postedn = 134NCT01080196
• Reducing Operative and Post-operative Morbidity in Living Kidney Donors With the Airseal System: Complete Statistical AnalysisIndependent statistical analysis of Reducing Operative and Post-operative Morbidity in Living Kidney Donors With the Airseal System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase NAResults postedn = 41NCT02262039
• REFLEXIONIndependent statistical analysis of Long-term Follow-Up of Patients Who Participated in Study 27025 (REFLEX): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00813709).Phase 3Results postedn = 402NCT00813709
• Regional Anesthesia Following Pediatric Cardiac Surgery: Complete Statistical AnalysisIndependent statistical analysis of Regional Anesthesia Following Pediatric Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05688670).Phase 4Results postedn = 52NCT05688670
• Rehabilitation in Primary Care: A Project to Maximize the Health Status of Adults With Chronic Illness: Complete Statistical AnalysisIndependent statistical analysis of Rehabilitation in Primary Care: A Project to Maximize the Health Status of Adults With Chronic Illness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase NAResults postedn = 303NCT00229957
• Relationship Between Attention and Emotional Regulation Post-Traumatic Brain Injury (TBI): Complete Statistical AnalysisIndependent statistical analysis of Relationship Between Attention and Emotional Regulation Post-Traumatic Brain Injury (TBI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01681589).Phase NAResults postedn = 40NCT01681589
• Relative Bioavailability Study of Ropinirole Implants in Parkinson’s Patients on L-Dopa Switched From Oral Ropinirole: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 1/2Results postedn = 6NCT03250117
• RELEASE MSS5Independent statistical analysis of Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 3Results postedn = 56NCT04984278
• Reliability of Consumer Sleep Trackers in Patients Suffering From Obstructive Sleep Apnea Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Reliability of Consumer Sleep Trackers in Patients Suffering From Obstructive Sleep Apnea Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase NAResults postedn = 36NCT02967367
• REMAINIndependent statistical analysis of A Phase IV Study of Rebif ® 44mcg Administered Three Times Per Week by Subcutaneous Injection Compared With no Treatment in the Therapy of Relapsing Multiple Sclerosis After…Phase 4Results postedn = 30NCT01142466
• RESCUE-Japan LIMITAn educational statistical analysis of RESCUE-Japan LIMIT, evaluating endovascular treatment for acute large vessel occlusion with large ischemic core. Includes trial design, the 90-day modified Rankin Scale endpoint, planned statistical analysis, and…Phase NAn = 203NCT03702413
• RESISTIndependent statistical analysis of Aspirin Resistance and Percutaneous Coronary Intervention (PCI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01103440).Phase 2Results postedn = 36NCT01103440
• RESISTIndependent statistical analysis of Remote Ischemic Conditioning in Patients With Acute Stroke (RESIST): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03481777).Phase NAResults postedn = 1,500NCT03481777
• REST-ITIndependent statistical analysis of Reducing Suicidal Ideation Through Insomnia Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01689909).Phase 4Results postedn = 103NCT01689909
• RESTORE-MEIndependent statistical analysis of Effects of a Resistance Training Program in Older Women With Sarcopenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 25NCT02628145
• RLS-PractiseIndependent statistical analysis of Non-interventional Study (NIS) in Patients With Restless Legs Syndrome in Daily Practise: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 687NCT01113710
• ROCKET AFIndependent statistical analysis of ROCKET AF, the randomized phase 3 trial of rivaroxaban versus warfarin for prevention of stroke and non-CNS systemic embolism in patients with non-valvular atrial fibrillation.Phase 3Results postedn = 14,269NCT00403767
• ROPIndependent statistical analysis of Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00634972).Phase 4Results postedn = 83NCT00634972
• SAFOIndependent statistical analysis of Orthotics in Ambulatory Cerebral Palsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01527162).Phase NAResults postedn = 11NCT01527162
• SALPIndependent statistical analysis of Pilot Study to Determine Effects of Salsalate in Type 1 Diabetes and Painful Peripheral Neuropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 8NCT01480297
• SAMURAIComplete statistical analysis of the phase 3 SAMURAI trial of lasmiditan versus placebo for acute migraine, including trial design, binary endpoints, logistic regression, odds ratios, confidence intervals, p-values, safety, and interpretation.Phase 3Results postedn = 2,231NCT02439320
• SAPPHIREA detailed statistical analysis of the SAPPHIRE phase 3 randomized trial of carotid artery stenting in patients with carotid artery disease, including its endpoints, design, planned time-to-event analysis, and statistical interpretation.Phase 3n = 1,300NCT00231270
• SBIndependent statistical analysis of An Evaluation of Rigid Sternal Fixation in Supporting Bone Healing and Improving Postoperative Recovery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase NAResults postedn = 236NCT01783483
• SCASTIndependent statistical analysis of SCAST, the Scandinavian Candesartan Acute Stroke Trial, including trial design, endpoints, planned statistical methods, and interpretation.Phase 3n = 2,500NCT00120003
• SCIPHSIndependent statistical analysis of Impact of Passive Heat on Metabolic, Inflammatory and Vascular Health in Persons With Spinal Cord Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase NAResults postedn = 10NCT04971408
• SCNSL1Independent statistical analysis of High-dose Sequential Chemoimmunotherapy for B-cell Lymphomas With Central Nervous System Involvement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2Results postedn = 40NCT00801216

← All therapeutic areas